메뉴 건너뛰기




Volumn 6, Issue 260, 2014, Pages

Endoscopic molecular imaging of human bladder cancer using a CD47 antibody

Author keywords

[No Author keywords available]

Indexed keywords

CD47 ANTIBODY; CD47 PROTEIN; DIAGNOSTIC AGENT; MESSENGER RNA; TUMOR MARKER; UNCLASSIFIED DRUG; CD47 ANTIGEN;

EID: 84908568498     PISSN: 19466234     EISSN: 19466242     Source Type: Journal    
DOI: 10.1126/scitranslmed.3009457     Document Type: Article
Times cited : (133)

References (39)
  • 2
    • 84883192924 scopus 로고    scopus 로고
    • Fluorescence-guided surgery with live molecular navigation-A new cutting edge
    • Q. T. Nguyen, R. Y. Tsien, Fluorescence-guided surgery with live molecular navigation-A new cutting edge. Nat. Rev. Cancer 13, 653-662 (2013).
    • (2013) Nat. Rev. Cancer , vol.13 , pp. 653-662
    • Nguyen, Q.T.1    Tsien, R.Y.2
  • 4
    • 76149083899 scopus 로고    scopus 로고
    • Update on the management of non-muscle invasive bladder cancer
    • S. Aldousari, W. Kassouf, Update on the management of non-muscle invasive bladder cancer. Can. Urol. Assoc. J. 4, 56-64 (2010).
    • (2010) Can. Urol. Assoc. J. , vol.4 , pp. 56-64
    • Aldousari, S.1    Kassouf, W.2
  • 5
    • 32944465832 scopus 로고    scopus 로고
    • Predicting recurrence and progression in individual patients with stage Ta T1 bladder cancer using EORTC risk tables: A combined analysis of 2596 patients from seven EORTC trials
    • discussion 475-477
    • R. J. Sylvester, A. P. Van Der Meijden, W. Oosterlinck, J. A. Witjes, C. Bouffioux, L. Denis, D. W. Newling, K. Kurth, Predicting recurrence and progression in individual patients with stage Ta T1 bladder cancer using EORTC risk tables: A combined analysis of 2596 patients from seven EORTC trials. Eur. Urol. 49, 466-475; discussion 475-477 (2006).
    • (2006) Eur. Urol. , vol.49 , pp. 466-475
    • Sylvester, R.J.1    Van Der Meijden, A.P.2    Oosterlinck, W.3    Witjes, J.A.4    Bouffioux, C.5    Denis, L.6    Newling, D.W.7    Kurth, K.8
  • 7
    • 84876482422 scopus 로고    scopus 로고
    • Action on Bladder Cancer, Current perspectives in bladder cancer management
    • T. R. Griffiths; Action on Bladder Cancer, Current perspectives in bladder cancer management. Int. J. Clin. Pract. 67, 435-448 (2013).
    • (2013) Int. J. Clin. Pract. , vol.67 , pp. 435-448
    • Griffiths, T.R.1
  • 8
    • 84863727612 scopus 로고    scopus 로고
    • New optical imaging technologies for bladder cancer: Considerations and perspectives
    • J. J. Liu, M. J. Droller, J. C. Liao, New optical imaging technologies for bladder cancer: Considerations and perspectives. J. Urol. 188, 361-368 (2012).
    • (2012) J. Urol. , vol.188 , pp. 361-368
    • Liu, J.J.1    Droller, M.J.2    Liao, J.C.3
  • 11
    • 69749100062 scopus 로고    scopus 로고
    • Optical biopsy of human bladder neoplasia with in vivo confocal laser endomicroscopy
    • G. A. Sonn, S. N. Jones, T. V. Tarin, C. B. Du, K. E. Mach, K. C. Jensen, J. C. Liao, Optical biopsy of human bladder neoplasia with in vivo confocal laser endomicroscopy. J. Urol. 182, 1299-1305 (2009).
    • (2009) J. Urol. , vol.182 , pp. 1299-1305
    • Sonn, G.A.1    Jones, S.N.2    Tarin, T.V.3    Du, C.B.4    Mach, K.E.5    Jensen, K.C.6    Liao, J.C.7
  • 16
    • 33644867290 scopus 로고    scopus 로고
    • Defining molecular profiles of poor outcome in patients with invasive bladder cancer using oligonucleotide microarrays
    • M. Sanchez-Carbayo, N. D. Socci, J. Lozano, F. Saint, C. Cordon-Cardo, Defining molecular profiles of poor outcome in patients with invasive bladder cancer using oligonucleotide microarrays. J. Clin. Oncol. 24, 778-789 (2006).
    • (2006) J. Clin. Oncol. , vol.24 , pp. 778-789
    • Sanchez-Carbayo, M.1    Socci, N.D.2    Lozano, J.3    Saint, F.4    Cordon-Cardo, C.5
  • 17
    • 57249116912 scopus 로고    scopus 로고
    • Boolean implication networks derived from large scale, whole genome microarray datasets
    • D. Sahoo, D. L. Dill, A. J. Gentles, R. Tibshirani, S. K. Plevritis, Boolean implication networks derived from large scale, whole genome microarray datasets. Genome Biol. 9, R157 (2008).
    • (2008) Genome Biol. , vol.9 , pp. R157
    • Sahoo, D.1    Dill, D.L.2    Gentles, A.J.3    Tibshirani, R.4    Plevritis, S.K.5
  • 19
    • 34547612220 scopus 로고    scopus 로고
    • Thirty years of BCG immunotherapy for non-muscle invasive bladder cancer: A success story with room for improvement
    • S. Brandau, H. Suttmann, Thirty years of BCG immunotherapy for non-muscle invasive bladder cancer: A success story with room for improvement. Biomed. Pharmacother. 61, 299-305 (2007).
    • (2007) Biomed. Pharmacother. , vol.61 , pp. 299-305
    • Brandau, S.1    Suttmann, H.2
  • 22
    • 67149084303 scopus 로고    scopus 로고
    • Histological variants of urothelial carcinoma: Diagnostic, therapeutic and prognostic implications
    • M. B. Amin, Histological variants of urothelial carcinoma: Diagnostic, therapeutic and prognostic implications. Mod. Pathol. 22, S96-S118 (2009).
    • (2009) Mod. Pathol. , vol.22 , pp. S96-S118
    • Amin, M.B.1
  • 25
    • 84908605864 scopus 로고    scopus 로고
    • National Library of Medicine, Bethesda, MD, cited 27 August 2014
    • Stanford University. Phase I trial of Hu5F9-G4. In: ClinicalTrials.gov [Internet] (National Library of Medicine, Bethesda, MD, 2000) [cited 27 August 2014]. Available at http://www.clinicaltrials. gov/ct2/show/NCT02216409?term=sikic&rank=2 NLM Identifier: NCT02216409.
    • (2000) Phase i Trial of Hu5F9-G4
    • Stanford University1
  • 26
    • 84872735928 scopus 로고    scopus 로고
    • Nanotoxicity assessment of quantum dots: From cellular to primate studies
    • K. T. Yong, W. C. Law, R. Hu, L. Ye, L. Liu, M. T. Swihart, P. N. Prasad, Nanotoxicity assessment of quantum dots: From cellular to primate studies. Chem. Soc. Rev. 42, 1236-1250 (2013).
    • (2013) Chem. Soc. Rev. , vol.42 , pp. 1236-1250
    • Yong, K.T.1    Law, W.C.2    Hu, R.3    Ye, L.4    Liu, L.5    Swihart, M.T.6    Prasad, P.N.7
  • 27
    • 84860190466 scopus 로고    scopus 로고
    • A molecular imaging primer: Modalities, imaging agents, and applications
    • M. L. James, S. S. Gambhir, A molecular imaging primer: Modalities, imaging agents, and applications. Physiol. Rev. 92, 897-965 (2012).
    • (2012) Physiol. Rev. , vol.92 , pp. 897-965
    • James, M.L.1    Gambhir, S.S.2
  • 33
    • 84863591835 scopus 로고    scopus 로고
    • Potential for clinical radionuclide-based imaging and therapy of common cancers expressing EGFR-family receptors
    • J. Carlsson, Potential for clinical radionuclide-based imaging and therapy of common cancers expressing EGFR-family receptors. Tumour Biol. 33, 653-659 (2012).
    • (2012) Tumour Biol. , vol.33 , pp. 653-659
    • Carlsson, J.1
  • 38
    • 79960696534 scopus 로고    scopus 로고
    • Epidermal growth factor receptor expression in urinary bladder cancer
    • D. S. Naik, S. Sharma, A. Ray, S. Hedau, Epidermal growth factor receptor expression in urinary bladder cancer. Indian J. Urol. 27, 208-214 (2011).
    • (2011) Indian J. Urol. , vol.27 , pp. 208-214
    • Naik, D.S.1    Sharma, S.2    Ray, A.3    Hedau, S.4
  • 39
    • 0034782994 scopus 로고    scopus 로고
    • Expression profiles of ErbB family receptors and prognosis in primary transitional cell carcinoma of the urinary bladder
    • N. H. Chow, S. H. Chan, T. S. Tzai, C. L. Ho, H. S. Liu, Expression profiles of ErbB family receptors and prognosis in primary transitional cell carcinoma of the urinary bladder. Clin. Cancer Res. 7, 1957-1962 (2001).
    • (2001) Clin. Cancer Res. , vol.7 , pp. 1957-1962
    • Chow, N.H.1    Chan, S.H.2    Tzai, T.S.3    Ho, C.L.4    Liu, H.S.5


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.